Optimal timing of anti-PD-1 antibody combined with chemotherapy administration in patients with NSCLC

A 3-day-delay sequential combination might increase antitumor responses and clinical benefits compared with the simultaneous combination.

Authors

Institutions

Publication Details

Journal
Journal for ImmunoTherapy of Cancer
Published
2024-12-01
DOI
https://doi.org/10.1136/jitc-2024-009627
Citations
16
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
4.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimal timing of anti-PD-1 antibody combined with chemotherapy administration in patients with NSCLC

Tung‐Tien Sun, Qitai Zhao, Horng‐Dar Wang, Yachang Huo et al.
16 citations
Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and Biomarkers
4.52
article

Optimal timing of anti-PD-1 antibody combined with chemotherapy administration in patients with NSCLC

Tung‐Tien Sun, Qitai Zhao, Horng‐Dar Wang, Yachang Huo, Shundong Cang, Wei Lv, Guohui Qin, Nayoung Han, Yujie Xu, Lihua Liu, Yi Zhang, Hong Liu, Dan Wang, Li Liu, Lijun Miao, Zhixin Zhang, Yaqing Liu, Hongjie Chen, Kaiyuan Guo, Yuqing Duan, Feifei Fan, Qingyang Lei, Songyun Ouyang, Shuangning Yang, Liping Wang, Chenhui Zhao
article en
16 citations

Abstract

A 3-day-delay sequential combination might increase antitumor responses and clinical benefits compared with the simultaneous combination.

Journal for ImmunoTherapy of CancerVol. 12(12)
Hebei Medical University (CN), Union Hospital (HK), Henan University (CN), Chinese Center For Disease Control and Prevention (CN), Chengdu University of Technology (CN), Zhengzhou University (CN), Fourth Hospital of Hebei Medical University (CN), Second Affiliated Hospital of Zhengzhou University (CN), Henan Provincial People's Hospital (CN), First Affiliated Hospital of Zhengzhou University (CN), Huazhong University of Science and Technology (CN)
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 4%
Cancer Immunotherapy and Biomarkers
4.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.